Advertising and Sponsorship
Pathways is a print and digital publication of the Canadian Lymphedema Framework (CLF) and is distributed in collaboration with its provincial partners. It is published four times per year in a Winter, Spring, Summer and Fall issue. The CLF does not guarantee, warrant or endorse any product or service advertised in their publication. The views expressed do not necessarily represent the views of the CLF, its provincial partners, Editorial Board, or CLF Directors. All advertising copy is subject to review by the Pathways Editorial Board.
Industry Partnerships with the CLF support Pathways and help advance topics that address the critical issue of promoting lymphedema education and awareness. A relationship with the Canadian Lymphedema Framework positions sponsoring organizations as champions of lymphedema educational practice among its targeted audience. Your sponsorship and advertising dollars help fund important initiatives of the Canadian Lymphedema Framework; an academic, clinical, and patient interest-holder collaboration working to improve the lymphedema care in Canada.
To discuss partnership and marketing opportunities contact us at: partnership@canadalymph.ca

Click to view a copy of our current advertising rates and specifications.
Contact us for a copy of our 2026-27 Partnership Prospectus. partnership@canadalymph.ca
Advertising orders can be placed by completing and returning the contract page of the Rates & Specifications card, above, or online at:
tinyURL.com/Pathways-Advertising

Editorial Policy for Paid Content
The Canadian Lymphedema Framework believes in protecting the credibility and integrity of contributors to our magazine. We strive to maintain a strict standard of publishing and journalistic ethics by adopting a total transparency model when it comes to editorial content. We make it clear which content in our magazine is advertising and which content is selected by the Editor and Editorial Board members.
The ads will look like ads and the editorial content will look like an article or column. If we receive an ad that looks too much like editorial content, we will require the advertiser to redesign it or we will add the words “Paid Advertisement” to the top of the page.
When we offer industry partners the option of paid content* as a benefit of their partnership package, we will always identify such content to readers and disclose the nature of sponsorship. All content is subject to the approval of the Editorial Board and CLF Executive.
We also make it clear to readers that inclusion in the magazine of advertising and other submitted content does not constitute endorsement of the material or any related product(s) by the magazine, the Editor, Editorial Board, or CLF.
Eligibility for Partnership and Advertising. Eligibility to purchase sponsorship/partnership packages and/or advertising with the CLF is limited to companies or other entities offering materials, products, or services of specific interest to our audience, as determined by the CLF.
Specific guidelines about our disclosures
- We disclose if any of the writers or contributors were sponsored by a particular advertiser or company.
- If the editor or writer obtained free products or service samples to write a review, we will disclose to the reader of such.
- Contributors that provide endorsements or testimonials must have actually used the product or service and base their comments on personal experience. They may not provide endorsement or testimonial based on a script provided by an advertiser.
- We will not allow any content from a contributor related to or mentioning a product or service that the contributor has a personal investment in or commercial tie to.
*Sponsored content examples: story format, “advertorial,” clinical trial results, case studies and research pieces. All material is subject to the approval of the CLF Executive and Editorial Board. Word count and proximity of advertisement is negotiable and at the discretion of the Editorial Board.
Advertising Deadlines
Because of strict timelines with Editorial Board reviews and publisher and printer deadlines, it is important that your advertisement be submitted by no later than midnight of the following deadlines:
| Issue | Advertising Deadline | Distribution |
| Summer 2026 | April 07, 2026 | June 2026 |
| Fall 2026 | July 07, 2026 | September 2026 |
| Winter 2027 | October 06, 2026 | December 2026 |
| Spring 2027 | January 05, 2027 | March 2027 |
| Summer 2027 | April 06, 2027 | June 2027 |
The Canadian Lymphedema Framework gratefully acknowledges the support of these industry advertisers:



















We acknowledge the support of the Government of Canada.
